XTL Biopharmaceuticals Nominates Gilai Dolev as External Director
XTL Biopharmaceuticals director Iris Shapira Yalon submitted her resignation on October 12, 2026, citing personal reasons. Her departure takes effect upon her successor's appointment or November 20, 2026, whichever comes first. The board nominated Gilai Dolev on October 14, 2026, as her replacement external director, s